4//SEC Filing
Schranz Jennifer 4
Accession 0001104659-20-090282
CIK 0001641640other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:08 PM ET
Size
4.5 KB
Accession
0001104659-20-090282
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-07-31$0.76/sh−301$229→ 168,444 total
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001735382
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 4:08 PM ET
- Size
- 4.5 KB